Photo from wikipedia
We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient… Click to show full abstract
We report in vivo selection of a severe acute respiratory syndrome coronavirus 2 spike mutation (Q493R) conferring simultaneous resistance to bamlanivimab and etesivimab. This mutation was isolated from a patient who had coronavirus disease and was treated with these drugs.
Keywords:
emergence sars;
mutation q493r;
cov spike;
spike protein;
sars cov;
mutation
Journal Title: Emerging Infectious Diseases
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Emerging Infectious Diseases
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!